AVTX Avalo Therapeutics, Inc.
Nasdaq · SEC CIK 1534120 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $8.50M 23 sales by 6 insiders
- Filings on record
- 184 since 2021-07-02, latest 2026-09-18 16:10
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Sullivan Christopher Ryan | CFO | — | $3.72M |
| Doyle Mittie | Chief Medical Off | — | $2.98M |
| VARKI PAUL | CLO | — | $1.51M |
| Goldman Jonathan | Dir | — | $163.0K |
| Chan Mitchell | Dir | — | $72.5K |
| Riley Jennifer | Chief Strategy Off | — | $52.0K |
| Truex Samantha | Dir | — | — |
| KANTOFF AARON | Dir | — | — |
| NEIL GARRY ARTHUR | CEO, Dir | — | — |
| KAPLAN GILLA | Dir | — | — |
Transactions 111
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-09-18 16:10 | 2026-09-16 | AVTX | Sullivan Christopher Ryan | CFO | M - OptEx | $9.88 | +12.4K | 52.3K | +31% | +$122.5K |
| DT | 2026-09-18 16:10 | 2026-09-16 | AVTX | Sullivan Christopher Ryan | CFO | S - Sale+OE | $16.33 | -12.4K | 39.9K | -24% | -$202.4K |
| DT | 2026-09-11 16:10 | 2026-09-10 | AVTX | Sullivan Christopher Ryan | CFO | M - OptEx | $8.04 | +10.2K | 50.1K | +26% | +$81.9K |
| DT | 2026-09-11 16:10 | 2026-09-10 | AVTX | Sullivan Christopher Ryan | CFO | S - Sale+OE | $17.62 | -10.2K | 39.9K | -20% | -$179.5K |
| DT | 2026-09-01 16:38 | 2026-08-28 | AVTX | Doyle Mittie | Chief Medical Off | M - OptEx | $8.04 | +679 | 52.5K | +1% | +$5,459 |
| DT | 2026-09-01 16:38 | 2026-08-28 | AVTX | Doyle Mittie | Chief Medical Off | S - Sale+OE | $20.00 | -679 | 51.8K | -1% | -$13.6K |
| DMT | 2026-08-19 16:10 | 2026-08-17+ | AVTX | Sullivan Christopher Ryan | CFO | M - OptEx | $9.88 | +71.9K | 70.9K | New | +$709.9K |
| DMT | 2026-08-19 16:10 | 2026-08-17+ | AVTX | Sullivan Christopher Ryan | CFO | S - Sale+OE | $19.94 | -72.7K | 39.9K | -65% | -$1.45M |
| DT | 2026-08-19 16:10 | 2026-08-17 | AVTX | Doyle Mittie | Chief Medical Off | M - OptEx | $12.65 | +1,000 | 52.8K | +2% | +$12.7K |
| DT | 2026-08-19 16:10 | 2026-08-17 | AVTX | Doyle Mittie | Chief Medical Off | S - Sale+OE | $20.00 | -1,000 | 51.8K | -2% | -$20.0K |
| 2026-08-12 16:10 | 2026-08-11 | AVTX | Riley Jennifer | Chief Strategy Off | S - Sale | $19.59 | -2,655 | 37.0K | -7% | -$52.0K | |
| DT | 2026-08-12 16:10 | 2026-08-10 | AVTX | Doyle Mittie | Chief Medical Off | M - OptEx | $8.04 | +679 | 52.5K | +1% | +$5,459 |
| DT | 2026-08-12 16:10 | 2026-08-10 | AVTX | Doyle Mittie | Chief Medical Off | S - Sale+OE | $20.00 | -679 | 51.8K | -1% | -$13.6K |
| DT | 2026-07-29 16:05 | 2026-07-27 | AVTX | Doyle Mittie | Chief Medical Off | M - OptEx | $12.65 | +1,000 | 52.8K | +2% | +$12.7K |
| DT | 2026-07-29 16:05 | 2026-07-27 | AVTX | Doyle Mittie | Chief Medical Off | S - Sale+OE | $20.00 | -1,000 | 51.8K | -2% | -$20.0K |
| DMT | 2026-07-02 16:05 | 2026-06-30 | AVTX | Doyle Mittie | Chief Medical Off | M - OptEx | $10.89 | +4,654 | 56.4K | +9% | +$50.7K |
| DT | 2026-07-02 16:05 | 2026-06-30 | AVTX | Doyle Mittie | Chief Medical Off | S - Sale+OE | $20.00 | -4,654 | 51.8K | -8% | -$93.1K |
| DT | 2026-06-25 17:24 | 2026-06-23 | AVTX | Doyle Mittie | Chief Medical Off | M - OptEx | $8.04 | +1,450 | 53.2K | +3% | +$11.7K |
| DT | 2026-06-25 17:24 | 2026-06-23 | AVTX | Doyle Mittie | Chief Medical Off | S - Sale+OE | $18.00 | -1,450 | 51.8K | -3% | -$26.1K |
| 2026-06-12 16:43 | 2026-06-10 | AVTX | Riley Jennifer | Chief Strategy Off | F - Tax | $13.10 | -588 | 39.7K | -1% | -$7,703 | |
| 2026-06-12 16:41 | 2026-06-10 | AVTX | VARKI PAUL | CLO | F - Tax | $13.10 | -1,081 | 32.6K | -3% | -$14.2K | |
| 2026-06-12 16:36 | 2026-06-10 | AVTX | Sullivan Christopher Ryan | CFO | F - Tax | $13.10 | -138 | 40.8K | -0.3% | -$1,808 | |
| 2026-06-12 16:26 | 2026-06-10 | AVTX | Doyle Mittie | Chief Medical Off | F - Tax | $13.10 | -1,084 | 51.8K | -2% | -$14.2K | |
| DT | 2026-06-01 16:05 | 2026-05-28 | AVTX | Doyle Mittie | Chief Medical Off | M - OptEx | $8.04 | +679 | 47.8K | +1% | +$5,459 |
| DT | 2026-06-01 16:05 | 2026-05-28 | AVTX | Doyle Mittie | Chief Medical Off | S - Sale+OE | $16.00 | -679 | 47.1K | -1% | -$10.9K |
| 2026-05-26 16:10 | 2026-05-21 | AVTX | Riley Jennifer | Chief Strategy Off | A - Grant | $0.00 | +34.2K | 36.9K | +1,288% | $0 | |
| 2026-05-26 16:10 | 2026-05-21 | AVTX | Sullivan Christopher Ryan | CFO | A - Grant | $0.00 | +39.9K | 40.3K | +9,433% | $0 | |
| 2026-05-26 16:10 | 2026-05-21 | AVTX | VARKI PAUL | CLO | A - Grant | $0.00 | +24.3K | 27.9K | +669% | $0 | |
| 2026-05-26 16:10 | 2026-05-21 | AVTX | Doyle Mittie | Chief Medical Off | A - Grant | $0.00 | +43.5K | 47.1K | +1,201% | $0 | |
| 2026-05-26 16:10 | 2026-05-21 | AVTX | NEIL GARRY ARTHUR | CEO, Dir | A - Grant | $0.00 | +100.2K | 190.3K | +111% | $0 | |
| DT | 2026-05-19 16:10 | 2026-05-15 | AVTX | Doyle Mittie | Chief Medical Off | M - OptEx | $12.65 | +3,000 | 6,622 | +83% | +$38.0K |
| DT | 2026-05-19 16:10 | 2026-05-15 | AVTX | Doyle Mittie | Chief Medical Off | S - Sale+OE | $18.76 | -3,000 | 3,622 | -45% | -$56.3K |
| DT | 2026-05-11 16:05 | 2026-05-07 | AVTX | Sullivan Christopher Ryan | CFO | M - OptEx | $9.88 | +18.6K | 19.0K | +4,399% | +$183.8K |
| DT | 2026-05-11 16:05 | 2026-05-07 | AVTX | Sullivan Christopher Ryan | CFO | S - Sale+OE | $24.12 | -18.6K | 423 | -98% | -$448.8K |
| DMT | 2026-05-07 16:18 | 2026-05-06 | AVTX | VARKI PAUL | CLO | M - OptEx | $12.53 | +75.1K | 78.7K | +2,066% | +$940.4K |
| DMT | 2026-05-07 16:18 | 2026-05-06 | AVTX | VARKI PAUL | CLO | S - Sale+OE | $20.17 | -75.1K | 3,634 | -95% | -$1.51M |
| DT | 2026-05-07 16:16 | 2026-05-06 | AVTX | Sullivan Christopher Ryan | CFO | M - OptEx | $8.04 | +47.0K | 47.4K | +11,111% | +$377.9K |
| DMT | 2026-05-07 16:16 | 2026-05-06 | AVTX | Sullivan Christopher Ryan | CFO | S - Sale+OE | $20.19 | -47.0K | 423 | -99% | -$948.7K |
| DMT | 2026-05-07 16:16 | 2026-05-05+ | AVTX | Doyle Mittie | Chief Medical Off | M - OptEx | $11.40 | +108.2K | 110.2K | +5,570% | +$1.23M |
| DMT | 2026-05-07 16:16 | 2026-05-05+ | AVTX | Doyle Mittie | Chief Medical Off | S - Sale+OE | $20.61 | -108.2K | 3,622 | -97% | -$2.23M |
| T | 2026-05-07 16:15 | 2026-05-06 | AVTX | Chan Mitchell | Dir | S - Sale | $22.88 | -3,167 | 3,166 | -50% | -$72.5K |
| MT | 2026-05-01 16:37 | 2026-04-29+ | AVTX | Sullivan Christopher Ryan | CFO | S - Sale | $13.16 | -16.9K | 423 | -98% | -$222.6K |
| DT | 2026-04-08 16:51 | 2026-04-06 | AVTX | Doyle Mittie | Chief Medical Off | M - OptEx | $12.65 | +3,970 | 7,592 | +110% | +$50.2K |
| DT | 2026-04-08 16:51 | 2026-04-06 | AVTX | Doyle Mittie | Chief Medical Off | S - Sale+OE | $18.01 | -3,970 | 3,622 | -52% | -$71.5K |
| MT | 2026-04-03 15:14 | 2026-04-01+ | AVTX | Sullivan Christopher Ryan | CFO | S - Sale | $16.96 | -16.0K | 17.3K | -48% | -$270.6K |
| DT | 2026-04-03 15:13 | 2026-04-01 | AVTX | Doyle Mittie | Chief Medical Off | M - OptEx | $8.04 | +679 | 4,301 | +19% | +$5,459 |
| DT | 2026-04-03 15:13 | 2026-04-01 | AVTX | Doyle Mittie | Chief Medical Off | S - Sale+OE | $16.00 | -679 | 3,622 | -16% | -$10.9K |
| D | 2026-03-31 | 2026-03-28 | AVTX | NEIL GARRY ARTHUR | CEO, Dir | M - OptEx | — | +64.9K | 112.0K | +138% | — |
| D | 2026-03-31 | 2026-03-28 | AVTX | NEIL GARRY ARTHUR | CEO, Dir | F - Tax | $13.89 | -21.9K | 90.1K | -20% | -$304.1K |
| D | 2026-03-31 | 2026-03-28 | AVTX | KAPLAN GILLA | Dir | M - OptEx | — | +3,166 | 6,333 | +100% | — |
| D | 2026-03-31 | 2026-03-28 | AVTX | Goldman Jonathan | Dir | M - OptEx | — | +3,166 | 3,166 | New | — |
| D | 2026-03-31 | 2026-03-28 | AVTX | KANTOFF AARON | Dir | M - OptEx | — | +3,166 | 6,333 | +100% | — |
| D | 2026-03-31 | 2026-03-28 | AVTX | Truex Samantha | Dir | M - OptEx | — | +3,166 | 6,333 | +100% | — |
| D | 2026-03-31 | 2026-03-28 | AVTX | Chan Mitchell | Dir | M - OptEx | — | +3,166 | 6,333 | +100% | — |
| D | 2026-03-31 | 2026-03-28 | AVTX | Sullivan Christopher Ryan | CFO | F - Tax | $13.89 | -8,241 | 33.3K | -20% | -$114.5K |
| D | 2026-03-31 | 2026-03-28 | AVTX | Sullivan Christopher Ryan | CFO | M - OptEx | — | +24.2K | 41.5K | +140% | — |
| DM | 2026-03-18 | 2026-03-16 | AVTX | Doyle Mittie | Chief Medical Off | M - OptEx | $11.57 | +25.5K | 29.1K | +704% | +$294.9K |
| D | 2026-03-18 | 2026-03-16 | AVTX | Doyle Mittie | Chief Medical Off | S - Sale+OE | $16.15 | -25.5K | 3,622 | -88% | -$411.7K |
| 2025-12-12 | 2025-12-10 | AVTX | VARKI PAUL | CLO | F - Tax | $4.10 | -1,016 | 3,634 | -22% | -$4,166 | |
| 2025-12-12 | 2025-12-10 | AVTX | Riley Jennifer | Chief Strategy Off | F - Tax | $4.10 | -637 | 2,655 | -19% | -$2,612 | |
| 2025-12-12 | 2025-12-10 | AVTX | Doyle Mittie | Chief Medical Off | F - Tax | $4.10 | -1,013 | 3,622 | -22% | -$4,153 | |
| 2025-12-12 | 2025-12-10 | AVTX | Sullivan Christopher Ryan | CFO | F - Tax | $4.10 | -155 | 17.3K | -0.9% | -$635.50 | |
| DM | 2025-11-17 | 2025-11-14 | AVTX | Goldman Jonathan | Dir | S - Sale+OE | $14.34 | -11.4K | 0 | -100% | -$163.0K |
| D | 2025-11-17 | 2025-11-14 | AVTX | Goldman Jonathan | Dir | M - OptEx | $9.88 | +8,200 | 8,200 | New | +$81.0K |
| D | 2025-04-01 | 2025-03-28 | AVTX | Truex Samantha | Dir | M - OptEx | — | +3,167 | 3,167 | New | — |
| D | 2025-04-01 | 2025-03-28 | AVTX | Sullivan Christopher Ryan | CFO | F - Tax | $8.46 | -7,285 | 16.9K | -30% | -$61.6K |
| D | 2025-04-01 | 2025-03-28 | AVTX | Sullivan Christopher Ryan | CFO | M - OptEx | — | +24.2K | 24.2K | +403,333% | — |
| D | 2025-04-01 | 2025-03-28 | AVTX | Goldman Jonathan | Dir | M - OptEx | — | +3,167 | 3,167 | New | — |
| D | 2025-04-01 | 2025-03-28 | AVTX | Chan Mitchell | Dir | M - OptEx | — | +3,167 | 3,167 | New | — |
| D | 2025-04-01 | 2025-03-28 | AVTX | KANTOFF AARON | Dir | M - OptEx | — | +3,167 | 3,167 | New | — |
| D | 2025-04-01 | 2025-03-28 | AVTX | KAPLAN GILLA | Dir | M - OptEx | — | +3,167 | 3,167 | New | — |
| D | 2025-04-01 | 2025-03-28 | AVTX | Almenoff June Sherie | Dir | M - OptEx | — | +3,167 | 3,167 | New | — |
| D | 2025-04-01 | 2025-03-28 | AVTX | NEIL GARRY ARTHUR | CEO | F - Tax | $8.46 | -17.8K | 47.1K | -27% | -$150.5K |
| D | 2025-04-01 | 2025-03-28 | AVTX | NEIL GARRY ARTHUR | CEO | M - OptEx | — | +64.9K | 64.9K | +108,112% | — |
| MI | 2024-11-14 | 2024-11-12+ | AVTX | Almenoff June Sherie | Dir | P - Purchase | $12.75 | +1,000 | 1,000 | New | +$12.8K |
| MI | 2023-06-28 | 2023-06-26+ | AVTX | Armistice Capital Master Fund Ltd. | 10% | S - Sale | $0.5871 | -3.68M | 1.67M | -69% | -$2.16M |
| I | 2023-06-27 | 2023-06-26 | AVTX | Caissa Capital Management ltd. | 10% | P - Purchase | $0.64 | -1.43M | 0 | -100% | -$912.4K |
| 2023-06-27 | 2023-06-26 | AVTX | Caissa Capital Management ltd. | 10% | P - Purchase | $0.62 | -182.3K | 0 | -100% | -$113.0K | |
| MI | 2023-06-20 | 2023-06-15+ | AVTX | Caissa Capital Management ltd. | 10% | P - Purchase | $3.87 | +8,160 | 1.43M | +0.6% | +$31.6K |
| MI | 2023-06-14 | 2023-06-12+ | AVTX | Caissa Capital Management ltd. | 10% | P - Purchase | $3.77 | +16.9K | 1.41M | +1% | +$63.6K |
| 2023-06-13 | 2023-06-09 | AVTX | NEIL GARRY ARTHUR | CEO, COB, Dir | P - Purchase | $3.42 | +4,000 | 13.2K | +43% | +$13.7K | |
| 2023-06-13 | 2023-06-09 | AVTX | Sullivan Christopher Ryan | CFO | P - Purchase | $3.42 | +511 | 1,262 | +68% | +$1,748 | |
| MI | 2023-06-09 | 2023-06-07+ | AVTX | Caissa Capital Management ltd. | 10% | P - Purchase | $3.91 | +14.4K | 1.40M | +1% | +$56.4K |
| I | 2023-06-02 | 2023-05-31 | AVTX | Caissa Capital Management ltd. | 10% | P - Purchase | $2.87 | +844 | 1.39M | +0.1% | +$2,422 |
| MI | 2023-05-30 | 2023-05-25+ | AVTX | Caissa Capital Management ltd. | 10% | P - Purchase | $2.80 | +2,671 | 1.39M | +0.2% | +$7,466 |
| MI | 2023-05-24 | 2023-05-24 | AVTX | Caissa Capital Management ltd. | 10% | P - Purchase | $2.98 | +9,000 | 1.38M | +0.7% | +$26.8K |
| MI | 2023-05-22 | 2023-05-18+ | AVTX | Caissa Capital Management ltd. | 10% | P - Purchase | $3.36 | +26.6K | 1.37M | +2% | +$89.4K |
| MI | 2023-05-16 | 2023-05-12+ | AVTX | Caissa Capital Management ltd. | 10% | P - Purchase | $2.52 | +4,379 | 1.35M | +0.3% | +$11.0K |
| MI | 2023-05-08 | 2023-05-04+ | AVTX | Caissa Capital Management ltd. | 10% | P - Purchase | $2.77 | +25.0K | 1.34M | +2% | +$69.3K |
| MI | 2023-04-27 | 2023-04-25+ | AVTX | Caissa Capital Management ltd. | 10% | P - Purchase | $2.99 | +7,500 | 1.32M | +0.6% | +$22.4K |
| MI | 2023-04-24 | 2023-04-20+ | AVTX | Caissa Capital Management ltd. | 10% | P - Purchase | $3.07 | +17.5K | 1.31M | +1% | +$53.6K |
| MI | 2023-04-18 | 2023-04-17+ | AVTX | Caissa Capital Management ltd. | 10% | P - Purchase | $2.95 | +25.0K | 1.29M | +2% | +$73.8K |
| MI | 2023-04-11 | 2023-04-10+ | AVTX | Caissa Capital Management ltd. | 10% | P - Purchase | $2.53 | +56.3K | 1.24M | +5% | +$142.4K |
| DI | 2023-02-09 | 2023-02-03 | AVTX | ARMISTICE CAPITAL, LLC | 10% | L - Small Acq | $3.95 | +334 | 3.96M | +0.0% | +$1,319 |
| DI | 2023-02-09 | 2023-02-07 | AVTX | ARMISTICE CAPITAL, LLC | 10% | P - Purchase | — | +450.0K | 4.42M | +11% | — |
| 2022-12-12 | 2022-12-09 | AVTX | NEIL GARRY ARTHUR | CEO, COB, Dir | P - Purchase | $4.42 | +2,083 | 9,220 | +29% | +$9,207 | |
| MI | 2022-03-14 | 2022-03-10+ | AVTX | ARMISTICE CAPITAL, LLC | Dir, 10% | P - Purchase | $0.6735 | +226.0K | 47.58M | +0.5% | +$152.2K |
| MI | 2022-03-07 | 2022-03-03+ | AVTX | Boyd Steven | Dir, 10% | P - Purchase | $0.6755 | +510.0K | 46.89M | +1% | +$344.5K |
| MI | 2022-02-28 | 2022-02-24+ | AVTX | Armistice Capital Master Fund Ltd. | Dir, 10% | P - Purchase | $0.7971 | +140.0K | 46.84M | +0.3% | +$111.6K |
| MI | 2022-02-22 | 2022-02-17+ | AVTX | Boyd Steven | Dir, 10% | P - Purchase | $0.8056 | +288.0K | 46.62M | +0.6% | +$232.0K |
Purchase Sale Sale after option exercise All abbreviations